Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset
Jin Hwa Hong et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2022)
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial
Tao Jiang et al.
MOLECULAR CANCER (2022)
Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature
Hao Wen et al.
FRONTIERS IN ONCOLOGY (2022)
Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes
Shan Zhu et al.
ONCOGENE (2022)
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
Yunuo Zhang et al.
BMC CANCER (2022)
Editorials Cervical screening: the evolving landscape
Jennifer C. Davies-Oliveira et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2022)
Recent Imaging Updates and Advances in Gynecologic Malignancies
Taher Daoud et al.
CANCERS (2022)
Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
Sidrah Shah et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Germline pathogenic variants associated with ovarian cancer: A historical overview
Emma Lund Johansen et al.
GYNECOLOGIC ONCOLOGY REPORTS (2022)
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
Haoyu Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Integrative Genomic Tests in Clinical Oncology
Evgeny Imyanitov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Human papillomavirus integration perspective in small cell cervical carcinoma
Xiaoli Wang et al.
NATURE COMMUNICATIONS (2022)
PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
Nannan Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Aarushi Audhut Caro et al.
CANCERS (2022)
Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting
Fernando Cotait Maluf et al.
FRONTIERS IN ONCOLOGY (2022)
A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
Yang Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China
Jing Liu et al.
BMC MEDICAL GENOMICS (2022)
PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial-mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma
Ako Yokoi et al.
CELL COMMUNICATION AND SIGNALING (2022)
Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective
Ning Li et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2022)
BRCA2 gene mutation in cancer
Chunbao Xie et al.
MEDICINE (2022)
Primary Fallopian Tube Carcinoma Presenting with a Massive Inguinal Tumor: A Case Report and Literature Review
Michihide Maeda et al.
MEDICINA-LITHUANIA (2022)
Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2
Lauren Clarfield et al.
CURRENT ONCOLOGY (2022)
A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
Yang Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
Weiwei Feng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas
Richard S. P. Huang et al.
ONCOLOGIST (2021)
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
Jenneke C. Kasius et al.
CANCERS (2021)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
Andres Poveda et al.
LANCET ONCOLOGY (2021)
Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma
Tao Jiang et al.
THERANOSTICS (2021)
Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids
Kadi Lohmussaar et al.
NATURE COMMUNICATIONS (2020)
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
Siwen Hu-Lieskovan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Breast cancer (BRCA) gene testing in ovarian cancer
Anca Chelariu-Raicu et al.
CHINESE CLINICAL ONCOLOGY (2020)
Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes
Malwina Suszynska et al.
GYNECOLOGIC ONCOLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Clinical actionability of molecular targets in endometrial cancer
Mary Ellen Urick et al.
NATURE REVIEWS CANCER (2019)
Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US
Cheng- Liao et al.
GYNECOLOGIC ONCOLOGY (2018)
Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
Min Chul Choi et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
The ExAC browser: displaying reference data information from over 60 000 exomes
Konrad J. Karczewski et al.
NUCLEIC ACIDS RESEARCH (2017)
Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study
Miranda M. Fidler et al.
LANCET ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
Integrated analysis of germline and somatic variants in ovarian cancer
Krishna L. Kanchi et al.
NATURE COMMUNICATIONS (2014)
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence
Inmaculada de Juan Jimenez et al.
FAMILIAL CANCER (2013)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
Neeraj Lalwani et al.
RADIOGRAPHICS (2011)
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube
Danielle Vicus et al.
GYNECOLOGIC ONCOLOGY (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)